Retrospective Cohort Study
Copyright ©The Author(s) 2023.
World J Gastroenterol. Jun 28, 2023; 29(24): 3843-3854
Published online Jun 28, 2023. doi: 10.3748/wjg.v29.i24.3843
Table 2 Hazard ratios for incident cancer according to lifestyle modification

No. of case (100 persons year)
HR (95%CI)
Hepatocellular carcinoma
    Control (n = 104560)5031 (0.8)Reference
    LSM1 (n = 48766)2296 (0.8)0.92 (0.87-0.96)
        QD (n = 8224)371 (0.7)0.84 (0.76-0.94)
        QS (n = 16423)695 (0.7)0.87 (0.81-0.94)
        RE (n = 14457)799 (0.9)1.08 (1.00-1.16)
        QD + QS + RE (n = 686)31 (0.7)0.79 (0.55-1.12)
All cancer
    Control (n = 104560)9691 (1.6)Reference
    LSM (n = 48766)4710 (1.6)0.93 (0.90-0.97)
        QD (n = 8224)826 (1.7)0.92 (0.86-0.99)
        QS (n = 16423)1411 (1.5)0.89 (0.84-0.94)
        RE (n = 14457)1506 (1.8)1.04 (0.99-1.10)
        QD + QS + RE (n = 686)70 (1.7)0.85 (0.67-1.07)
Extrahepatic cancer
    Control (n = 104560)4660 (0.8)Reference
    LSM (n = 48766)2414 (0.8)0.96 (0.91-1.01)
        QD (n = 8224)455 (0.9)1.01 (0.92-1.11)
        QS (n = 16423)716 (0.8)0.91 (0.84-0.99)
        RE (n = 14457)707 (0.8)1.00 (0.93-1.09)
        QD + QS + RE (n = 686)39 (0.9)0.91 (0.67-1.25)